New meta-analysis finds oral anticoagulants reduce net adverse events in patients with atrial fibrillation after intracranial hemorrhage but with a higher risk for recurrent intracranial hemorrhage.

The triggering receptor expressed on myeloid cells 2 (TREM2) plays a pivotal role in the activation of myeloid cells and is ...

A large meta-analysis has found that the drug leading the charge in anti-aging science is just as effective in protecting cells and cognitive function as cutting calories or intermittent fasting ...

Drug combination shows promise for early treatment after myocardial infarction by Germans Trias i Pujol Research Institute edited by Gaby Clark, reviewed by Robert Egan Editors' notes ...

A New Study Says You Can Delay Death—but Not the Speed of Aging The rate of human aging is remarkably constant, even if it does begin later in life.

Higher stroke risk was seen overall, and higher risk of acute myocardial infarction was seen in those with Down syndrome under 40 years of age. HealthDay News — Individuals with Down syndrome are at ...

In healthy aging, carb quality counts Study links midlife intakes of high-quality carbohydrates and dietary fiber to better health in older women Date: May 16, 2025 Source: Tufts University ...

Risk of Poor Cardiovascular Outcomes Up in Aging Patients With Down Syndrome Higher stroke risk seen overall, and higher risk of acute myocardial infarction seen in those with Down syndrome under 40 ...

A version of this article appears in print on May 13, 2025, Section D, Page 7 of the New York edition with the headline: A Longevity Expert’s Tips for Aging Well.

Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial ...

As the heart ages, its ability to recover from myocardial infarction diminishes, leading to significant changes in energy utilization and eventually heart failure.